<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is one of the most common causes of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Because there is currently no useful serological marker for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e>, the search for simple biomarkers for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> diagnosis and prognosis is needed </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="16336">Hyaluronic acid</z:chebi> level was determined by ELISA; in addition to its degrading enzymes, degradation products and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> were determined by standard techniques in 185 CRC patients with and without <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Statistical analyses were performed by logistic regression and receiver-operating characteristic (ROC) curves </plain></SENT>
<SENT sid="4" pm="."><plain>The multivariate discriminate analysis (<z:chebi fb="14" ids="32506">MDA</z:chebi>) selects a function based on absolute values of six biochemical markers; score = [-0.62 (numerical constant) + <z:chebi fb="1" ids="16336">hyaluronic acid</z:chebi> (pg/l) × 0.002 + hyaluronidase (mg N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="5417">glucosamine</z:chebi>/ml/18 h) × 0.009-β-glucuronidase (μmol/ml/min) × 0.07 + N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-β-D-glucosaminidase (μmol/ml/min) × 0.019-<z:chebi fb="0" ids="24298">glucuronic acid</z:chebi> (μg/dl) × 0.001 + nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (μmol/l) × 0.01] </plain></SENT>
<SENT sid="5" pm="."><plain>The selected <z:chebi fb="14" ids="32506">MDA</z:chebi> function correctly classified 92% of the metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients at a discriminate cut-off score = 0.24 (i.e., less than 0.24 indicated patients with non-metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and greater than 0.24 indicated patients with metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> with high degrees of sensitivity (100%) and specificity (93%)) </plain></SENT>
<SENT sid="6" pm="."><plain>The positive predictive and negative predictive values were also high (81% and 85%, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> patients can be simply and efficiently classified into metastatic or non-metastatic using their <z:chebi fb="14" ids="32506">MDA</z:chebi> score </plain></SENT>
</text></document>